Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression.

Neuroscience
Mark A CervinskiRoxanne A Vaughan

Abstract

We investigated the functional relationship between the soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE) protein syntaxin 1A (syn 1A) and the dopamine transporter (DAT) by treating rat striatal tissue with Botulinum Neurotoxin C (BoNT/C) and co-transfecting syn 1A with DAT in non-neuronal cells, followed by analysis of DAT activity, phosphorylation, and regulation. Treatment of striatal slices with BoNT/C resulted in elevated dopamine (DA) transport Vmax and reduced DAT phosphorylation, while heterologous co-expression of syn 1A led to reduction in DAT surface expression and transport Vmax. Syn 1A was present in DAT immunoprecipitation complexes, supporting a direct or indirect interaction between the proteins. Phorbol ester regulation of DA transport activity was retained in BoNT/C-treated synaptosomes and syn 1A transfected cells, demonstrating that protein kinase C (PKC) and syn 1A effects occur through independent processes. These findings reveal a novel mechanism for regulation of DAT activity and phosphorylation, and suggest the potential for syn 1A to impact DA neurotransmission through effects on reuptake.

References

Sep 28, 1999·Trends in Pharmacological Sciences·G W MillerM G Caron
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·C SaundersA Galli
Mar 7, 2001·JAMA : the Journal of the American Medical Association·S S ArnonUNKNOWN Working Group on Civilian Biodefense
Nov 16, 2001·Biochemical Society Transactions·J HaaseC Williams
May 8, 2002·The Journal of Biological Chemistry·James D FosterRoxanne A Vaughan
Aug 15, 2002·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Michael W Quick
Feb 8, 2003·Brain Research. Molecular Brain Research·James D FosterRoxanne A Vaughan
Sep 17, 2003·The Journal of Pharmacology and Experimental Therapeutics·Limen Chi, Maarten E A Reith
Nov 13, 2003·European Journal of Pharmacology·Ole V Mortensen, Susan G Amara
Oct 27, 2004·Pharmacology & Therapeutics·Haley E Melikian
Dec 21, 2004·Molecular and Cellular Neurosciences·Charles T YokoyamaWilliam A Catterall
Jan 7, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Devadoss J SamuvelSammanda Ramamoorthy
Mar 15, 2005·Journal of Neuroscience Methods·Roxanne A VaughanJoseph B Justice
Jun 16, 2005·Progress in Neurobiology·David SulzerAurelio Galli
Aug 20, 2005·The Journal of Biological Chemistry·Manuel MirandaAlexander Sorkin
Sep 27, 2005·Neuropharmacology·Balachandra K Gorentla, Roxanne A Vaughan
Apr 26, 2006·Journal of Neurochemistry·Gonzalo E Torres
Dec 26, 2006·Molecular and Cellular Neurosciences·Uhna Sung, Randy D Blakely
Jan 17, 2007·The Journal of Biological Chemistry·Makoto TaniguchiShin-ichi Hisanaga
Apr 23, 2008·The Journal of Biological Chemistry·Julie KniazeffUlrik Gether
Jun 24, 2008·Nature Neuroscience·Thijs BeumingClaus J Loland
Jul 12, 2008·Molecular Pharmacology·Francesca BindaAurelio Galli
Sep 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Lucia CarvelliLouis J DeFelice
Jan 17, 2009·Biochemistry·Balachandra K GorentlaRoxanne A Vaughan

❮ Previous
Next ❯

Citations

Jul 30, 2011·Biochemistry·Jonathan J Sager, Gonzalo E Torres
Nov 20, 2012·The Journal of Biological Chemistry·Amy E MoritzRoxanne A Vaughan
Apr 11, 2012·Genes, Brain, and Behavior·C D BryantA A Palmer
Apr 5, 2013·PloS One·Jennie Garcia-OlivaresGonzalo E Torres
Jan 15, 2014·Neurochemistry International·Michael NguyenAllan V Kalueff
Jun 3, 2014·Molecular and Cellular Neurosciences·Laura M VecchioAli Salahpour
Mar 20, 2013·Molecular Aspects of Medicine·Akula Bala PramodL Keith Henry
Jun 22, 2011·Journal of Neurochemistry·Melissa A StoufferMargaret E Rice
Aug 24, 2013·Trends in Pharmacological Sciences·Roxanne A Vaughan, James D Foster
Jan 17, 2015·European Journal of Pharmacology·S Mechiel KorteBerend Olivier
Sep 25, 2012·Frontiers in Neuroendocrinology·Jennifer C Felger, Andrew H Miller
Sep 4, 2016·Pharmacological Reviews·Daniel P Bermingham, Randy D Blakely
Apr 14, 2012·Journal of Affective Disorders·Marion LeboyerDavid J Kupfer
Nov 12, 2016·Journal of Chemical Neuroanatomy·James D Foster, Roxanne A Vaughan
Jul 15, 2011·Pharmacological Reviews·Anders S KristensenUlrik Gether
Mar 7, 2020·The Journal of Biological Chemistry·Rita R FaganHaley E Melikian
Oct 2, 2015·The Journal of Biological Chemistry·Amy E MoritzJames D Foster
Jan 30, 2021·The Journal of Biological Chemistry·Rita R FaganHaley E Melikian
Apr 10, 2019·ACS Chemical Neuroscience·Danielle E BollandJames D Foster
Oct 16, 2021·Molecular Psychiatry·Maarten E A ReithZhicheng Lin
Oct 29, 2021·Cellular and Molecular Life Sciences : CMLS·Dolores PiniellaFrancisco Zafra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.